John P. Butler, CEO and President at Akebia Therapeutics, Inc. (AKBA), sold 93,140 shares at $1.58 ($147K) on 2024-02-29, disclosed to the SEC on 2024-03-01.
Seasonal sale ($147k) by CEO and President — this insider has traded AKBA in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.58 | 46,570 | $74K | 50.0% |
| 2 | $1.58 | 46,570 | $74K | 50.0% |
| Total | $1.58 avg | 93,140 | $147K | 100% |
| Filing → |
| AKBA | SELL | 2025-03-04 | $170K | — | Filing → |
| AKBA | SELL | 2025-02-04 | $606K | — | Filing → |
| AKBA | SELL | 2024-02-29 | $115K | — | Filing → |